| __timestamp | PTC Therapeutics, Inc. | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 79838000 | 19586000 |
| Thursday, January 1, 2015 | 121816000 | 29135000 |
| Friday, January 1, 2016 | 117633000 | 42791000 |
| Sunday, January 1, 2017 | 117456000 | 49577000 |
| Monday, January 1, 2018 | 171984000 | 89209000 |
| Tuesday, January 1, 2019 | 257452000 | 69099000 |
| Wednesday, January 1, 2020 | 477643000 | 75961000 |
| Friday, January 1, 2021 | 540684000 | 90467000 |
| Saturday, January 1, 2022 | 651496000 | 74552000 |
| Sunday, January 1, 2023 | 666563000 | 91593000 |
In pursuit of knowledge
In the competitive world of biopharmaceuticals, strategic investment in research and development (R&D) is crucial for innovation and growth. Over the past decade, PTC Therapeutics, Inc. and Supernus Pharmaceuticals, Inc. have demonstrated contrasting approaches to R&D spending. From 2014 to 2023, PTC Therapeutics increased its R&D expenses by over 730%, peaking at approximately $667 million in 2023. This aggressive investment strategy underscores their commitment to pioneering new therapies. In contrast, Supernus Pharmaceuticals maintained a more conservative growth in R&D spending, with a 368% increase over the same period, reaching around $92 million in 2023. This difference highlights the varied strategic focuses of these companies, with PTC Therapeutics prioritizing rapid innovation and Supernus Pharmaceuticals balancing R&D with other business objectives. As the biopharma landscape evolves, these investment strategies will play a pivotal role in shaping their future trajectories.
R&D Insights: How Zoetis Inc. and Supernus Pharmaceuticals, Inc. Allocate Funds
GSK plc vs PTC Therapeutics, Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Insmed Incorporated and Supernus Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Bio-Techne Corporation and PTC Therapeutics, Inc.
R&D Insights: How Sarepta Therapeutics, Inc. and PTC Therapeutics, Inc. Allocate Funds
Research and Development Investment: Halozyme Therapeutics, Inc. vs PTC Therapeutics, Inc.
Research and Development Expenses Breakdown: Lantheus Holdings, Inc. vs Supernus Pharmaceuticals, Inc.
Alkermes plc vs Supernus Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: Alpine Immune Sciences, Inc. and Supernus Pharmaceuticals, Inc.
R&D Insights: How Apellis Pharmaceuticals, Inc. and PTC Therapeutics, Inc. Allocate Funds
Research and Development: Comparing Key Metrics for PTC Therapeutics, Inc. and Perrigo Company plc
Analyzing R&D Budgets: Vericel Corporation vs Supernus Pharmaceuticals, Inc.